Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Immuron Limited ( (AU:IMC) ) is now available.
Immuron Limited announced the cessation of 2,560,000 securities due to the expiry of options without exercise or conversion, effective July 21, 2025. This cessation may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and future growth prospects.
More about Immuron Limited
Immuron Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases.
Average Trading Volume: 138,301
Technical Sentiment Signal: Sell
Current Market Cap: A$17.88M
For detailed information about IMC stock, go to TipRanks’ Stock Analysis page.